Atlas Trials

Olanzapine for the Treatment of Appetite Loss in Amyotrophic Lateral Sclerosis (ALS)

Clinical trial NCT00876772 · COMPLETED

Trial details

NCT number
NCT00876772
Sponsor
Charite University, Berlin, Germany
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Amyotrophic Lateral Sclerosis (ALS)
Start date
2011-03-01
Primary completion
2012-07-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.